NCT04186884

Brief Summary

This trial studies caregiver burden, quality of life, and symptom distress of patients and their informal (unpaid) caregivers at different palliative care settings. Cancer caregiving may affect a caregiver's life physically, emotionally, socially, and financially. Studying caregiver burden may help investigators learn about caregivers' opinions on stress of caregiving, and about the factors related to caregiver burdens.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
351

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 26, 2019

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 28, 2019

Completed
8 months until next milestone

First Posted

Study publicly available on registry

December 5, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2021

Completed
Last Updated

March 3, 2022

Status Verified

March 1, 2022

Enrollment Period

2.6 years

First QC Date

March 28, 2019

Last Update Submit

March 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Severity of subjective stress burden (emotional impact) in caregivers of patients seen at the Supportive Care Center (SCC) and at the Palliative Care Unit (PCU)

    Measured by the Montgomery-Borgatta Caregiver Burden Scale. (4-item sub-scale questionnaire to measure the degree caregivers perceive their tasks and evaluates emotional effects of caregiving has a (Cronbach Alpha ranging from 0.68 to 0.82.)

    Day 1, day of enrollment

Secondary Outcomes (5)

  • Objective burden (impact on tangible aspects of life Questionnaire

    Day 1, day of enrollment

  • Subjective demand burden (impact on the patient-caregiver relationship) of caregivers

    Day 1, day of enrollment

  • Caregiver quality of life and symptoms of distress

    Day 1, day of enrollment

  • Caregiver symptom distress

    Day 1, day of enrollment

  • Factors that are associated with caregiver burden, quality of life, and symptom distress Questionnaires

    Day 1, day of enrollment

Study Arms (1)

Observational (questionnaires)

Patients and caregivers visiting SCC for a consult or admitted to PCU complete questionnaires over 35 minutes.

Other: Quality-of-Life AssessmentOther: Questionnaire Administration

Interventions

Ancillary studies

Also known as: Quality of Life Assessment
Observational (questionnaires)

Complete questionnaires

Observational (questionnaires)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients visiting the SCC for a first consultation or patients admitted to the PCU at MD Anderson Cancer Center and primary informal caregiver of patient

You may qualify if:

  • ( SCC Patient) Patients visiting the SCC for a first consultation.
  • (SCC Patient) Patients who can identify a primary informal caregiver.
  • (SCC Patient) Diagnosis of advanced cancer defined as locally advanced, recurrent, or metastatic.
  • (SCC Patient) Be able to read and speak English.
  • (SCC Patient) 18 years of age or older.
  • (Caregiver of SCC Patient) Be identified or self-identified as a primary informal caregiver of the patient. The caregiver could be present or verbally agree to participate.
  • (Caregiver of SCC Patient) Be able to read and speak English.
  • (Caregiver of SCC Patient) 18 years of age or older.
  • (Caregiver of SCC Patient) Caregivers who are not able to complete the assessment on the day of patients' first consultation must be willing to engage in a telephone assessment with research staff +/- 3 days after.
  • (PCU Patient) Patients who have been admitted to the PCU at MD Anderson Cancer Center.
  • (PCU Patient) Patients should have a primary informal caregiver during their PCU stay.
  • (PCU Patient) Diagnosis of advanced cancer defined as locally advanced, recurrent, or metastatic.
  • (PCU Patient) Be able to read and speak English.
  • (PCU Patient) 18 years of age or older.
  • (Caregiver of PCU Patient) Be identified by the patient or self-identified as the primary informal caregiver of the patient. The caregiver should be present with the patient during PCU stay.
  • +2 more criteria

You may not qualify if:

  • (SCC Patient) Refusal to participate in this study. This study requires both patient and caregiver enrollment.
  • (SCC Patient) Patients with only paid caregivers.
  • (SCC Patient) Patients with cognitive impairment as identified by research staff, treating physician or nurse.
  • (Caregiver of SCC Patient) Refusal to participate in this study. This study requires both patient and caregiver enrollment.
  • (Caregiver of SCC Patient) Patients with no caregivers or patients with only paid caregivers.
  • (PCU Patient) Refusal to participate in this study. This study requires both patient and caregiver enrollment.
  • (PCU Patient) Patients with no caregivers or patients with only paid caregivers.
  • (PCU Patient) Patients with cognitive impairment as identified by research staff, treating physician or nurse.
  • (Caregiver of PCU Patient) Refusal to participate in this study. This study requires both patient and caregiver enrollment.
  • (Caregiver of PCU Patient) Patients with no caregivers or patients with only paid caregivers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Neoplasm MetastasisRecurrence

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Study Officials

  • Kimberson C Tanco

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2019

First Posted

December 5, 2019

Study Start

March 26, 2019

Primary Completion

November 5, 2021

Study Completion

November 5, 2021

Last Updated

March 3, 2022

Record last verified: 2022-03

Locations